ADMA (ADMA Biologics Inc) Net Profit

ADMA (ADMA Biologics, Inc.) - company brandmark

ADMA Biologics is striving for dominance in the plasma-derived medicines segment by developing its own raw material collection centers to maximize profits. Its leadership in immunodeficiency therapies is complemented by strict adherence to FDA bio-waste disposal regulations. The company's net profit chart on GURU.Markets confirms this trend, where the parameter value equals 0.17, separating real financial growth from market noise.

ADMA (ADMA Biologics) Net Profit history from 07/04/2022 to 10/29/2026
Core merchandise of ADMA Bio

The integration of proprietary plasma collection centers and drug production within ADMA Biologics (ADMA) is directly reflected in the company's annual financial results, confirming the efficiency of its closed-loop cycle. This indicator captures the final net profit after deducting all operating and tax expenses, allowing investors to assess the business's actual ability to generate cash flow and determine the fair market value of the asset.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income PTGX (Protagonist)|IMVT (Immunovant Inc) - Final Profit|Net Profit KNSA (Kiniksa Pharmaceuticals Ltd)|Net Financial Result Grifols Biemat (GRFS)|ADPT - Company Net Income|celldex.com (CLDX) - Net Income|Aurinia Pharmaceuticals Inc. (AUPH) - Company Net Income|Net Income BioCryst Pharmaceuticals, Inc.|Net Income VERA|Net Profit Dianthus Corp|Company Net Income Pharvaris N.V. (PHVS)|AbCellera Biologics Inc. - Company Profit|Net Profit TRML (Tourmaline Bio)|Precigen Inc (PGEN) - Company Net Income|Pharming - Net Profit|NKTR - Net Profit|UPB: Net Profit|Company Profit ZBIO|Company Net Income Immunome|Net Income Gossamer Bio Inc (GOSS)|Net Profit KALV|Net Profit Septerna Pharma (SEPN)|Pieris Pharmaceuticals - Net Income|Final Profit SVRA|Rigel Pharmaceuticals, Inc. - Net Profit|ANAB: Company Net Income|ATXS: Net Profit|ENGN - Net Financial Result|Company Net Income RAPT Therapeutics, Inc.|Company Net Income Aerovate JBIO|Company Net Income Aclaris Therapeutics, Inc. (ACRS)|Company Net Income KYTX (Kyverna Therapeutics Inc.)|Company Net Income Tiziana Life Sciences PLC TLSA|Cabaletta Bio Inc (CABA) - Company Net Income|Ventyx Biosciences - Net Profit|Annual Net Income theratech.com (THTX)|AVTX: Net Profit|ELDN - Net Financial Result|AGEN (Agenus Inc) - Net Profit|Net Income Climb Bio, Inc (CLYM)|Company Net Income Zura Bio Limited (ZURA)|Net Financial Result atyrpharma.com|Net Profit ADAG (Adagene Inc.)|Net Profit ImageneBio IMA|Shattuck Therapeutics - Net Profit|EQ (Equillium, Inc.) - Company Profit|connectbiopharm.com (CNTB) - Company Net Income|Net Income Immunic|ATRA (Atara Biotherapeutics, Inc.) - Net Profit|Net Profit InflaRx GmbH|Company Net Income X4 Pharma (XFOR)|ACET: Profit After Tax|Net Profit CELU (Celularity)|Final Profit INMB|Barinthus Biotherapeutics plc - Net Profit|KZR - Net Profit|SAB Biotherapeutics, Inc (SABS) - Company Net Income|Akari Therapeutics, Plc - Final Profit|Company Net Income Enlivex Therapeutics Ltd|Net Income Q32 Bio Corp (QTTB)|Net Profit GOVX|Net Profit Edesa Biotech Inc (EDSA)|iBio Corp - Net Income|Final Profit CARM|XTL Biopharmaceuticals - Net Profit|Net Financial Result Bolt Biotherapeutics BOLT|hcwbiologics.com (HCWB) - Company Net Income|Net Income Aptevo Therapeutics Inc.|Company Net Income AIM ImmunoTech|Net Income Aditxt Corp (ADTX)|Net Income GRI (GRI Bio, Inc.)|Net Profit xortx.com (XRTX)|Company Net Income Vyome Holdings HIND|REVB: Company Profit|Indaptus - Net Profit|Company Net Income BiondVax Pharmaceuticals|CALI: Net Profit|Affimed N.V. (AFMD) - Net Profit|ALLK (Allakos Inc) - Net Profit|Company Profit HOOK (HOOKIPA)|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Net Profit OCEA (Ocean Biomedical, Inc.)|Net Profit tcbiopharm.com TCBP|THRD: Net Income